Symbiotec Pharmalab IPO Allotment Status Online

The Symbiotec Pharmalab IPO allotment status will be available on the allotment date on August 28, 2026, Friday. The Symbiotec Pharmalab IPO subscription was ended on August 27, 2026, Thursday.

The investors who applied for the IPO will be able to check the Symbiotec Pharmalab IPO allotment status online on the MUFG Intime India Pvt. Ltd. website or the BSE, NSE website. The IPO was subscribed 75.08 times overall. The IPO GMP went around ₹270 level after the subscription ended.

Symbiotec Pharmalab IPO

Symbiotec Pharmalab IPO Allotment Date

As per the timeline, the Symbiotec Pharmalab IPO allotment date is August 28, 2026, Friday. The investors can check the IPO allotment via the registrar website of MUFG Intime or the BSE, NSE website. Investors can check the allotment status online and offline with easy steps given below:

Registrar:MUFG Intime IPO Allotment Page
BSE: BSE IPO Allotment Page
NSE: NSE IPO Allotment Page
IPO Watch:IPO Allotment Status Page

Check Symbiotec Pharmalab’ IPO Allotment Status on Registrar site?

  1. Visit MUFG Intime India Pvt. Ltd. website
  2. Select IPO Name ‘Symbiotec Pharmalab’ from the drop-down menu on the page
  3. Enter details required like PAN Card, Application Number, or Demat Account Number
  4. Click on the ‘Search’ Button, and;
  5. Get your allotment on the your screen

Check Symbiotec Pharmalab IPO Allotment Status on BSE?

  1. Visit BSE India IPO Allotment Page
  2. Select the issue type: equity/debt
  3. Select IPO Name ‘Symbiotec Pharmalab’ from the drop-down menu on the page
  4. Enter details required like PAN Card or Application Number
  5. Click on the ‘Search’ Button, and;
  6. Get your allotment on the your screen

Check Symbiotec Pharmalab IPO Allotment Status on NSE?

  1. Visit NSE India IPO Allotment Page
  2. Select the issue type
  3. Select IPO Name ‘Symbiotec Pharmalab’ from the drop-down menu on the page
  4. Enter details required like PAN Card or Application Number
  5. Click on the ‘Search’ Button, and;
  6. Get your allotment on the your screen

IPO Subscription Details

CategoryDay 1Day 2Day 3Day 4
QIB0.370.570.62181.20
NII1.103.1612.8677.56
bNII0.822.5911.9087.34
sNII1.664.3014.7858.01
RII1.012.225.3813.69
EMP1.653.196.2516.32
Total0.851.955.6275.08

Symbiotec Pharmalab IPO Key Dates

IPO Open Date:August 24, 2026
IPO Close Date:August 27, 2026
Basis of Allotment:August 28, 2026
Refunds:August 31, 2026
Credit to Demat Account:August 31, 2026
IPO Listing Date:September 1, 2026

Business Overview

Symbiotec Pharmalab is a pharmaceutical and biotechnology company with over 30 years of experience. It mainly manufactures Corticosteroid and Steroidal Hormone APIs, which are important ingredients used to make medicines. 

The company has grown from a small laboratory-scale steroid manufacturer into a fully integrated global company. In FY2025, Symbiotec had a strong share of the global market for these APIs and was the only Indian and global company present across the top 10 categories in this market. 

In FY2025, they were a global leader by volume in the production of Corticosteroid and Steroidal-Hormone Active Pharmaceutical Ingredients (APIs).

Note for the Investors

Symbiotec Pharmalab IPO Registrar is responsible for the IPO allotment and refund process. If you have any queries regarding the Symbiotec Pharmalab IPO Allotment date and time please contact the registrar with your queries.

Symbiotec Pharmalab IPO Allotment Status FAQs


When is Symbiotec Pharmalab IPO Allotment Date?

Symbiotec Pharmalab IPO Allotment is to be available on August 28, 2026, Friday.

What will be Symbiotec Pharmalab IPO Refund Date?

The IPO refund date is August 31, 2026, Monday.

How to check the Symbiotec Pharmalab IPO Allotment Status?

Check Symbiotec Pharmalab IPO allotment status via your PAN number, the application number, or the amount deducted in your bank.

Picture of Jagat Joshi

Jagat Joshi

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.
Picture of Jagat Joshi

Jagat Joshi

Join WhatsApp Channel